Mycobacterium tuberculosis infection of end-stage renal disease patients in Taiwan: a nationwide longitudinal study  S.-Y. Li, T.-J. Chen, K.-W. Chung,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review  X.-F. Gao, Z.-W. Yang, J. Li  International.
Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Molecular evolution of Mycobacterium tuberculosis
Patterns of delays in diagnosis amongst patients with smear-positive pulmonary tuberculosis at a teaching hospital in Turkey  E. Okur, A. Yilmaz, A. Saygi,
MariLia Bahiense Oliveira, Joao Egidio Romao, Roberto Zatz 
Benchmarking inappropriate empirical antibiotic treatment
Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome  J. Guinea, M. Torres-Narbona, P.
M. Inghammar, G. Engström, G. Kahlmeter, B. Ljungberg, C. -G
Gut bacterial microbiota and obesity
Salvage therapy for multidrug-resistant tuberculosis
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
Herpes zoster in non-hospitalized children
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
Mycobacterial peritonitis: difference between non-tuberculous mycobacteria and Mycobacterium tuberculosis  C.-C. Shu, J.-T. Wang, J.-Y. Wang, C.-J. Yu,
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Recurrent late-onset sepsis in the neonatal intensive care unit: incidence, clinical characteristics and risk factors  M.-H. Tsai, S.-M. Chu, C.-W. Lee,
R. Cantón  Clinical Microbiology and Infection 
Multicentre surveillance of prevalence of the 23S rRNA A2058G and A2059G point mutations and molecular subtypes of Treponema pallidum in Taiwan, 2009–2013 
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
E. Cambau, M. Drancourt  Clinical Microbiology and Infection 
PPE protein (Rv3425) from DNA segment RD11 of Mycobacterium tuberculosis: a potential B-cell antigen used for serological diagnosis to distinguish vaccinated.
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
J. Cairo, R. Hachem, G. Rangaraj, B. Granwehr, I. Raad 
M. Nørgaard, H. Larsson, G. Pedersen, H.C. Schønheyder, H.T. Sørensen 
Vector control: a cornerstone in the malaria elimination campaign
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Characterization of Mycobacterium tuberculosis isolated from cancer patients with suspected tuberculosis infection in Egypt: identification, prevalence,
Training for the infectious diseases speciality in Norway
E.C. Böttger  Clinical Microbiology and Infection 
Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia  S.-C. Kuo, Y.-T. Lee,
Retrospective study of CMV retinitis in patients with AIDS
R. Karakus, K. Caglar, C. Aybay  Clinical Microbiology and Infection 
Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated.
Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae.
Salvage therapy for multidrug-resistant tuberculosis
Elements of design: the knowledge on which we build
Levofloxacin in the treatment of ventilator-associated pneumonia
Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose  P. Savard, T.M. Perl  Clinical Microbiology.
Metagenomics and probiotics
Gender differences in treatment outcomes of tuberculosis patients in Taiwan: a prospective observational study  J.-Y. Feng, S.-F. Huang, W.-Y. Ting, Y.-C.
Long-term mortality following bloodstream infection
H. M. El Sahly, L.D. Teeter, J.M. Musser, E.A. Graviss 
Abstracts cont. Clinical Microbiology and Infection
Benchmarking inappropriate empirical antibiotic treatment
Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial 
Tuberculosis transmission patterns among Spanish-born and foreign-born populations in the city of Barcelona  S. Borrell, G. Tudó, E. Rey, J. González-Martín 
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria  E. Presterl, F. Daxböck, W. Graninger,
Tuberculosis in HIV-infected patients: a comprehensive review
Nebulized hypertonic saline treatment in hospitalized children with moderate to severe viral bronchiolitis  Z. Luo, Z. Fu, E. Liu, X. Xu, X. Fu, D. Peng,
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Mixed infection with Beijing and non-Beijing strains in pulmonary tuberculosis in Taiwan: prevalence, risk factors, and dominant strain  J.-Y. Wang, H.-L.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan  Yi-Chun.
Localized Mycobacterium avium complex infection in a patient on HAART
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Long-term outcomes after nucleos(t)ide analogue discontinuation in HBeAg-positive chronic hepatitis B patients  D. He, S. Guo, P. Zhu, S. Tao, M. Li,
Presentation transcript:

Mycobacterium tuberculosis infection of end-stage renal disease patients in Taiwan: a nationwide longitudinal study  S.-Y. Li, T.-J. Chen, K.-W. Chung, L.-W. Tsai, W.-C. Yang, J.-Y. Chen, T.-W. Chen  Clinical Microbiology and Infection  Volume 17, Issue 11, Pages 1646-1652 (November 2011) DOI: 10.1111/j.1469-0691.2011.03473.x Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Patient selection flow chart. ESRD, end-stage renal disease; MTB, Mycobacterium tuberculosis; RRT, renal replacement therapy. Clinical Microbiology and Infection 2011 17, 1646-1652DOI: (10.1111/j.1469-0691.2011.03473.x) Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Kaplan–Meier plots of the risk factors for Mycobacterium tuberculosis (MTB) infection among end-stage renal disease (ESRD) patients. Kaplan–Meier plots of cumulative MTB infection rate among ESRD patients, stratified by gender (a), age (b), hyperlipidaemia (c), hypertension (d), chronic obstructive pulmonary disease (COPD) (e), silicosis (f), monthly salary (g), and renal replacement modality (h). HD, haemodialysis; PD, peritoneal dialysis. Clinical Microbiology and Infection 2011 17, 1646-1652DOI: (10.1111/j.1469-0691.2011.03473.x) Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions